BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 34650558)

  • 1. Human Wharton's Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients.
    Mrahleh MA; Matar S; Jafar H; Wehaibi S; Aslam N; Awidi A
    Front Immunol; 2021; 12():732549. PubMed ID: 34650558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wharton's Jelly Mesenchymal Stromal Cells from Human Umbilical Cord: a Close-up on Immunomodulatory Molecules Featured In Situ and In Vitro.
    Corsello T; Amico G; Corrao S; Anzalone R; Timoneri F; Lo Iacono M; Russo E; Spatola GF; Uzzo ML; Giuffrè M; Caprnda M; Kubatka P; Kruzliak P; Conaldi PG; La Rocca G
    Stem Cell Rev Rep; 2019 Dec; 15(6):900-918. PubMed ID: 31741193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.
    Donders R; Vanheusden M; Bogie JF; Ravanidis S; Thewissen K; Stinissen P; Gyselaers W; Hendriks JJ; Hellings N
    Cell Transplant; 2015; 24(10):2077-98. PubMed ID: 25310756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis.
    Park A; Park H; Yoon J; Kang D; Kang MH; Park YY; Suh N; Yu J
    Stem Cell Res Ther; 2019 Feb; 10(1):66. PubMed ID: 30795812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially.
    Prasanna SJ; Gopalakrishnan D; Shankar SR; Vasandan AB
    PLoS One; 2010 Feb; 5(2):e9016. PubMed ID: 20126406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of transplanted human Wharton's jelly mesenchymal stem cells treated with IFN-γ on experimental autoimmune encephalomyelitis mice.
    Torkaman M; Ghollasi M; Mohammadnia-Afrouzi M; Salimi A; Amari A
    Cell Immunol; 2017 Jan; 311():1-12. PubMed ID: 27697286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory effects of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells.
    Saeidi M; Masoud A; Shakiba Y; Hadjati J; Mohyeddin Bonab M; Nicknam MH; Latifpour M; Nikbin B
    Iran J Allergy Asthma Immunol; 2013 Mar; 12(1):37-49. PubMed ID: 23454777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
    Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
    Front Immunol; 2020; 11():54. PubMed ID: 32117234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic Mice.
    Tsai PJ; Wang HS; Lin GJ; Chou SC; Chu TH; Chuan WT; Lu YJ; Weng ZC; Su CH; Hsieh PS; Sytwu HK; Lin CH; Chen TH; Shyu JF
    Cell Transplant; 2015; 24(8):1555-70. PubMed ID: 25198179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation.
    Li X; Bai J; Ji X; Li R; Xuan Y; Wang Y
    Int J Mol Med; 2014 Sep; 34(3):695-704. PubMed ID: 24970492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
    Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
    Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect and mechanisms of human Wharton's jelly-derived mesenchymal stem cells on type 1 diabetes in NOD model.
    Hu J; Wang Y; Wang F; Wang L; Yu X; Sun R; Wang Z; Wang L; Gao H; Fu Z; Zhao W; Yan S
    Endocrine; 2015 Feb; 48(1):124-34. PubMed ID: 24590294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Analyses of Immunosuppressive Characteristics of Bone-Marrow, Wharton's Jelly, and Adipose Tissue-Derived Human Mesenchymal Stem Cells.
    Karaöz E; Çetinalp Demircan P; Erman G; Güngörürler E; Eker Sarıboyacı A
    Turk J Haematol; 2017 Aug; 34(3):213-225. PubMed ID: 27610554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor.
    Najar M; Raicevic G; Boufker HI; Fayyad-Kazan H; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Tissue Eng Part A; 2010 Nov; 16(11):3537-46. PubMed ID: 20597819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into endometrial cells.
    Shi Q; Gao J; Jiang Y; Sun B; Lu W; Su M; Xu Y; Yang X; Zhang Y
    Stem Cell Res Ther; 2017 Nov; 8(1):246. PubMed ID: 29096715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Evaluation of interferon-gamma primed human Wharton's jelly-derived mesenchymal stem cells.
    Park SJ; Kim DS; Choi M; Han KH; Han JS; Yoo KH; Moon KS
    Hum Exp Toxicol; 2023; 42():9603271231171650. PubMed ID: 37092667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.
    Najar M; Raicevic G; Jebbawi F; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Immunol Lett; 2012 Aug; 146(1-2):50-6. PubMed ID: 22575528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive properties of Wharton's jelly-derived mesenchymal stromal cells in vitro.
    He H; Nagamura-Inoue T; Takahashi A; Mori Y; Yamamoto Y; Shimazu T; Tsunoda H; Tojo A
    Int J Hematol; 2015 Sep; 102(3):368-78. PubMed ID: 26228529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes.
    Zhou C; Yang B; Tian Y; Jiao H; Zheng W; Wang J; Guan F
    Cell Immunol; 2011; 272(1):33-8. PubMed ID: 22004796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.